Researchers at Stanford have developed a highly efficient (>90%) holographic beam steering method for obtaining distance information of objects nearby, with applications from autonomous vehicles to home appliances.
Researchers at Stanford have developed a tunable metasurface with high reflectance and large phase modulation for use as optical phase modulators or beam steering device (Lidar). Currently, the large size of beam steering devices is a critical problem.
Stanford researchers at the Thakor Lab have developed methods for kidney tissue regeneration using pulsed focused ultrasound (pFUS) therapy with mesenchymal stromal cells (MSCs) and/or MSC-derived extracellular vesicles (e.g., exosomes or microvesicles).
Genetic engineering of biological systems is a fundamental tool for both basic and translation research, where up- and down-regulation of gene expression is necessary to drive cellular phenotypes and evaluate gene function.
Our researcher has developed a mouse model of 16p11.2 deletion syndrome. A copy number variation on human chromosome 16p11.2 is among the most common genetic variations found in autism spectrum disorders.
The emergence of SARS-CoV-2 variants during the COVID-19 pandemic has demonstrated a need for broad immunization, such as provided by multivalent vaccines.
Researchers in the Appel lab have developed hydrogels for tumor inoculation that improve precision and statistical power in preclinical mouse models of cancer.
This invention is an intraoral palate expanding plate with an expansion screw for both cleft palate and restricted airways that can be produced by 3-D printing and CT scans.
A team of Stanford computer scientists have developed software that can serve as a key enabling technology for location-aware services indoors. Location-aware services are an important emerging technology for mobile devices.
Stanford inventor Dr. Anne Liu has developed an algorithm that can assess the risk of allergic reaction to antibiotics and help clinicians make decisions about which antibiotic to prescribe in patients who have a history of antibiotic allergies at the point-of-care.
Researchers at Stanford have found that nascent polypeptide-associated complex (NAC) and the apical domain of CCT1, as well as peptide fragments and fusion proteins containing them, can be used to suppress pathological protein aggregation.